Cochrane · systematic review · CD011725
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
Martín‐Saborido, C, López‐Alcalde, J, Ciapponi, A, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library
InjuriesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
0
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 5 · 100%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Indomethacin for controlling intracranial hypertension secondary to severe traumatic brain injury
Population: adults presenting with elevated intracranial pressure secondary to a traumatic brain injury
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intracranial pressure (mmHg) | no estimate extracted | 0 studies · 0 participants | Ungraded |
Mortality one month after the start of therapy | no estimate extracted | 0 studies · 0 participants | Ungraded |
Adverse effects considered as serious by either the patient or the clinician | no estimate extracted | 0 studies · 0 participants | Ungraded |
Disability (measured by the Glasgow Outcome Scale; higher score is better) | no estimate extracted | 0 studies · 0 participants | Ungraded |
Differences in quality of life ( | no estimate extracted | 0 studies · 0 participants | Ungraded |